Ironsides Asset Advisors, LLC Amicus Therapeutics, Inc. Transaction History

Ironsides Asset Advisors, LLC

  • $347 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 10, 2020
SELL
$12.89 - $15.89 $157,515 - $194,175
-12,220 Closed
0 $0
Q2 2020

Aug 07, 2020
BUY
$8.86 - $15.69 $886 - $1,569
100 Added 0.83%
12,220 $184,000
Q1 2020

May 11, 2020
BUY
$6.63 - $11.16 $80,355 - $135,259
12,120 New
12,120 $112,000

Others Institutions Holding FOLD

# of Institutions
317
Shares Held
315M
Call Options Held
530K
Put Options Held
569K
View Full List

About AMICUS THERAPEUTICS, INC.

FOLD Quotes by TradingView
  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.74B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Ironsides Asset Advisors, LLC Portfolio

Follow Ironsides Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ironsides Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ironsides Asset Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email